Halozyme Therapeutics Inc (NAS:HALO)
$ 48.13 0.1 (0.21%) Market Cap: 6.12 Bil Enterprise Value: 6.95 Bil PE Ratio: 15.94 PB Ratio: 13.52 GF Score: 87/100

Q3 2024 Halozyme Therapeutics Inc Earnings Call Transcript

Oct 31, 2024 / 08:30PM GMT
Release Date Price: $50.57 (-0.04%)
Operator

Good afternoon. My name is Jay and I'll be your conference operator today. At this time, I would like to welcome everyone today to Halozyme third quarter, 2024 financial and operating results conference call lines have been placed on mute to prevent any back.

After the speaker's remarks, there will be a question and answer session. If you would like to ask a question this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question. Press star one again, please note this event is being recorded.

I'll now turn the call over to Tram Bui, Halozyme's Vice President of Investor Relations and corporate Communications. Please go ahead.

Tram Bui
Halozyme Therapeutics Inc - Vice President - Investor Relations and Corporate Communications

Thank you operator. Good afternoon and welcome to our third quarter, 2024 financial and operating results conference call. In addition to the press release issued today after the market closed, you could find a supplementary slide presentation that will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot